Michael V. Ortiz, MD

About Me

I am a pediatric oncologist who cares for children and young adults with solid tumors. I have a particular expertise in treating pediatric sarcomas, liver cancers, and kidney cancers such as Wilms’ tumor. Through a combination of quality care, education, and research, I strive to improve the outcomes and experiences of children with cancer.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

My research is primarily focused on translating basic scientific discoveries into safer and more effective treatments for children and young adults with high-risk solid tumors. I investigate how these cancers become resistant to our treatments, screen new drugs against laboratory models of childhood cancers, and identify markers to predict which patients would benefit from these additional therapies. Ultimately my research aims to move the most promising treatments from the lab and into the clinic in order to help patients when their cancer has become resistant to standard therapies.

I am honored to work alongside a dedicated team of healthcare professionals. Our doctors, nurse practitioners, nurses, pharmacists, social workers, and others are committed to providing the best possible care for every child.

  • Clinical Expertise: Rare Pediatric Tumors; Kidney Cancers, Liver Cancers, Sarcomas; Relapsed and Refractory Solid Tumors in Children and Young Adults; Developmental Therapeutics
  • Languages Spoken: English
  • Education: MD, University of Florida
  • Residencies: Pediatrics - Children’s National Medical Center
  • Fellowships: Pediatric Hematology/Oncology – Memorial Sloan Kettering Cancer Center

See My Colleagues

Publications

Visit PubMed for a full listing of Michael V. Ortiz’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.

Insurance

Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.